| 000 | 01053 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514004046.0 | ||
| 264 | 0 | _c20010816 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a1389-2002 | ||
| 024 | 7 |
_a10.2174/1389200003339063 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWidner, B | |
| 245 | 0 | 0 |
_aInterferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences. _h[electronic resource] |
| 260 |
_bCurrent drug metabolism _cSep 2000 |
||
| 300 |
_a193-204 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunity, Cellular _xphysiology |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aTryptophan _xmetabolism |
| 700 | 1 | _aLedochowski, M | |
| 700 | 1 | _aFuchs, D | |
| 773 | 0 |
_tCurrent drug metabolism _gvol. 1 _gno. 2 _gp. 193-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389200003339063 _zAvailable from publisher's website |
| 999 |
_c11392926 _d11392926 |
||